Use of modern scores to evaluate individual risk/benefit of prolonged Dual AntiPlatelet Therapy may modify Dual AntiPlatelet Therapy duration in ST-segment elevation myocardial infarction patients
Archives of Cardiovascular Diseases Supplements · 2018
DOI: 10.1016/j.acvdsp.2017.11.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Cardiovascular Diseases Supplements, 2018. Verfasst von C. Caze und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Caze, C., Range, G., Bejan-Angoulvant, T., & Angoulvant, D. (2018). Use of modern scores to evaluate individual risk/benefit of prolonged Dual AntiPlatelet Therapy may modify Dual AntiPlatelet Therapy duration in ST-segment elevation myocardial infarction patients. Archives of Cardiovascular Diseases Supplements. https://doi.org/10.1016/j.acvdsp.2017.11.007
Vancouver
Caze C, Range G, Bejan-Angoulvant T, Angoulvant D. Use of modern scores to evaluate individual risk/benefit of prolonged Dual AntiPlatelet Therapy may modify Dual AntiPlatelet Therapy duration in ST-segment elevation myocardial infarction patients. Archives of Cardiovascular Diseases Supplements. 2018. doi:10.1016/j.acvdsp.2017.11.007
BibTeX
@article{Caze2018,
author = {Caze, C. and Range, G. and Bejan-Angoulvant, T. and Angoulvant, D.},
title = {Use of modern scores to evaluate individual risk/benefit of prolonged Dual AntiPlatelet Therapy may modify Dual AntiPlatelet Therapy duration in ST-segment elevation myocardial infarction patients},
journal = {Archives of Cardiovascular Diseases Supplements},
year = {2018},
doi = {10.1016/j.acvdsp.2017.11.007}
}
EUVIMED